Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 327537, 8 pages
http://dx.doi.org/10.1155/2014/327537
Research Article

Lobe-Specific Heterogeneity in Asymmetric Dimethylarginine and Matrix Metalloproteinase Levels in a Rat Model of Obstructive Cholestasis

1Department of Internal Medicine and Therapeutics, IRCCS S. Matteo Foundation, University of Pavia, 27100 Pavia, Italy
2Department of Molecular Medicine, IRCCS S. Matteo Foundation, University of Pavia, 27100 Pavia, Italy

Received 28 February 2014; Revised 23 May 2014; Accepted 26 May 2014; Published 12 June 2014

Academic Editor: Kim Bridle

Copyright © 2014 Andrea Ferrigno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Miyoshi, C. Rust, P. J. Roberts, L. J. Burgart, and G. J. Gores, “Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas,” Gastroenterology, vol. 117, no. 3, pp. 669–677, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Portincasa, I. Grattagliano, M. Testini et al., “Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants,” Free Radical Biology and Medicine, vol. 42, no. 9, pp. 1381–1391, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. F. C. Richardson, J. A. Boucheron, M. C. Dyroff, J. A. Popp, and J. A. Swenberg, “Biochemical and morphologic studies of heterogeneous lobe responses in hepatocarcinogenesis,” Carcinogenesis, vol. 7, no. 2, pp. 247–251, 1986. View at Google Scholar · View at Scopus
  4. R. D. Irwin, J. S. Parker, E. K. Lobenhofer et al., “Transcriptional profiling of the left and median liver lobes of male F344/N rats following exposure to acetaminophen,” Toxicologic Pathology, vol. 33, no. 1, pp. 111–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Faa, V. Nurchi, L. Demelia et al., “Uneven hepatic copper distribution in Wilson's disease,” Journal of Hepatology, vol. 22, no. 3, pp. 303–308, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Regev, M. Berho, L. J. Jeffers et al., “Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection,” American Journal of Gastroenterology, vol. 97, no. 10, pp. 2614–2618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Palladini, A. Ferrigno, V. Rizzo et al., “Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers,” Toxicologic Pathology, vol. 40, no. 5, pp. 722–730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. D. E. Malarkey, K. Johnson, L. Ryan, G. Boorman, and R. R. Maronpot, “New insights into functional aspects of liver morphology,” Toxicologic Pathology, vol. 33, no. 1, pp. 27–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. U. Ruepp, R. P. Tonge, J. Shaw, N. Wallis, and F. Pognan, “Genomics and proteomics analysis of acetaminophen toxicity in mouse liver,” Toxicological Sciences, vol. 65, no. 1, pp. 135–150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Chang, I. Lin, J. Sheen et al., “Sex differences of oxidative stress to cholestatic liver and kidney injury in young rats,” Pediatrics and Neonatology, vol. 54, no. 2, pp. 95–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kimoto, G. J. Whitley, H. Tsuji, and T. Ogawa, “Detection of N(G),N(G)-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody,” Journal of Biochemistry, vol. 117, no. 2, pp. 237–238, 1995. View at Google Scholar · View at Scopus
  12. M. Kimoto, H. Tsuji, T. Ogawa, and K. Sasaoka, “Detection of N(G),N(G)-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody,” Archives of Biochemistry and Biophysics, vol. 300, no. 2, pp. 657–662, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Nijveldt, T. Teerlink, M. P. C. Siroen, A. A. Van Lambalgen, J. A. Rauwerda, and P. A. M. Van Leeuwen, “The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA),” Clinical Nutrition, vol. 22, no. 1, pp. 17–22, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Palm, M. L. Onozato, Z. Luo, and C. S. Wilcox, “Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 6, pp. H3227–H3245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Hattori, K. Kasai, and S. S. Gross, “Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 276, no. 6, pp. H2020–H2028, 1999. View at Google Scholar · View at Scopus
  16. A. E. Kossakowska, D. R. Edwards, S. S. Lee et al., “Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis,” American Journal of Pathology, vol. 153, no. 6, pp. 1895–1902, 1998. View at Google Scholar · View at Scopus
  17. Y.-L. Tain and C. Baylis, “Determination of dimethylarginine dimethylaminohydrolase activity in the kidney,” Kidney International, vol. 72, no. 7, pp. 886–889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Esterbauer and K. H. Cheeseman, “Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal,” Methods in Enzymology, vol. 186, pp. 407–421, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Chomczynski and K. Mackey, “Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation,” Analytical Biochemistry, vol. 225, no. 1, pp. 163–164, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  21. D. E. Kleiner and W. G. Stetler-Stevenson, “Quantitative zymography: detection of picogram quantities of gelatinases,” Analytical Biochemistry, vol. 218, no. 2, pp. 325–329, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Tozzi, G. Palladini, S. Fallarini et al., “Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy,” American Journal of Hypertension, vol. 20, no. 6, pp. 663–669, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Tain, Y. Kao, C. Hsieh et al., “Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine,” Free Radical Biology and Medicine, vol. 49, no. 6, pp. 1088–1098, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Yang, T. Lee, Y. Huang et al., “Asymmetric dimethylarginine (ADMA) determines the improvement of hepatic endothelial dysfunction by vitamin E in cirrhotic rats,” Liver International, vol. 32, no. 1, pp. 48–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Garcia-Moreno, G. Vallejo, J. L. Arias, M.-A. Aller, L. Lorente, and J. Arias, “Behaviour of nucleolar organizer regions in the different Wistar rat liver lobes,” Laboratory Animals, vol. 28, no. 1, pp. 50–54, 1994. View at Google Scholar · View at Scopus
  26. H. F. Teutsch, D. Schuerfeld, and E. Groezinger, “Three-dimensional reconstruction of parenchymal units in the liver of the rat,” Hepatology, vol. 29, no. 2, pp. 494–505, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. L. W. Duchen, “The effects of deprivation of portal blood on the liver and its influence on carbon tetrachloride liver injury in the rat,” British Journal of Experimental Pathology, vol. 42, pp. 247–252, 1961. View at Google Scholar · View at Scopus
  28. G. U. Denk, C. J. Soroka, A. Mennone, H. Koepsell, U. Beuers, and J. L. Boyer, “Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis,” Hepatology, vol. 39, no. 5, pp. 1382–1389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Teerlink, Z. Luo, F. Palm, and C. S. Wilcox, “Cellular ADMA: regulation and action,” Pharmacological Research, vol. 60, no. 6, pp. 448–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. T. Nies, H. Koepsell, S. Winter et al., “Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver,” Hepatology, vol. 50, no. 4, pp. 1227–1240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. T. A. Lawson and A. W. Pound, “The different susceptibility of rat liver lobes to carbon tetrachloride and dimethylnitrosamine,” British Journal of Experimental Pathology, vol. 55, no. 6, pp. 583–588, 1974. View at Google Scholar · View at Scopus
  32. M. Aller, J. Arias, J. García-Domínguez, J. Arias, M. Durán, and J. Arias, “Experimental obstructive cholestasis: the wound-like inflammatory liver response,” Fibrogenesis & Tissue Repair, vol. 1, no. 1, p. 6, 2008. View at Publisher · View at Google Scholar
  33. A. M. Gressner and R. Weiskirchen, “Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets,” Journal of Cellular and Molecular Medicine, vol. 10, no. 1, pp. 76–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Gastroenterology, vol. 134, no. 6, pp. 1655–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Parola, F. Marra, and M. Pinzani, “Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario,” Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 58–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Weerachayaphorn, Y. Luo, A. Mennone, C. J. Soroka, K. Harry, and J. L. Boyer, “Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice,” Journal of Hepatology, vol. 60, no. 1, pp. 160–166, 2014. View at Publisher · View at Google Scholar
  37. M. Yang, A. Ramachandran, H. Yan et al., “Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice,” Toxicology Letters, vol. 224, no. 2, pp. 186–195, 2014. View at Publisher · View at Google Scholar
  38. S. Matsuzaki, M. Onda, T. Tajiri, and D. Y. Kim, “Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve,” Hepatology, vol. 25, no. 4, pp. 828–832, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Jacobsson, E. Jonas, P. M. Hellström, and S. A. Larsson, “Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients,” Journal of Gastroenterology, vol. 40, no. 7, pp. 733–738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. P. Larson, S. P. Bowers, N. A. Palekar, J. A. Ward, J. P. Pulcini, and S. A. Harrison, “Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass,” Clinical Gastroenterology and Hepatology, vol. 5, no. 11, pp. 1329–1332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Sumiyoshi, Y. Shima, R. Tokorodani et al., “CT/99mTc-GSA SPECT fusion images demonstrate functional differences between the liver lobes,” World Journal of Gastroenterology, vol. 19, no. 21, pp. 3217–3225, 2013. View at Publisher · View at Google Scholar · View at Scopus